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Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology
characteristic of amyotrophic lateral sclerosis in neuronal cells
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal and rapidly progressing neurodegenerative disorder and the
majority of ALS is sporadic, where misfolding and aggregation of Cu/Zn-superoxide dismutase (SOD1) is a
feature shared with familial mutant-SOD1 cases. ALS is characterized by progressive neurospatial spread of
pathology among motor neurons, and recently the transfer of extracellular, aggregated mutant SOD1 between
cells was demonstrated in culture. However, there is currently no evidence that uptake of SOD1 into cells
initiates neurodegenerative pathways reminiscent of ALS pathology. Similarly, whilst dysfunction to the ER-
Golgi compartments is increasingly implicated in the pathogenesis of both sporadic and familial ALS, it
remains unclear whether misfolded, wildtype SOD1 triggers ER-Golgi dysfunction. In this study we show that
both extracellular, native wildtype and mutant SOD1 are taken up by macropinocytosis into neuronal cells.
Hence uptake does not depend on SOD1 mutation or misfolding. We also demonstrate that purified mutant
SOD1 added exogenously to neuronal cells inhibits protein transport between the ER-Golgi apparatus,
leading to Golgi fragmentation, induction of ER stress and apoptotic cell death. Furthermore, we show that
extracellular, aggregated, wildtype SOD1 also induces ER-Golgi pathology similar to mutant SOD1, leading
to apoptotic cell death. Hence extracellular misfolded wildtype or mutant SOD1 induce dysfunction to ER-
Golgi compartments characteristic of ALS in neuronal cells, implicating extracellular SOD1 in the spread of
pathology among motor neurons in both sporadic and familial ALS.
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Abstract   amyotrophic  lateral sclerosis (aLS)  is a fatal 
and rapidly progressing neurodegenerative disorder and the 
majority of aLS is sporadic, where misfolding and aggre- 
gation of Cu/Zn-superoxide dismutase (SOD1) is a feature 
shared with familial mutant-SOD1 cases. aLS  is charac- 
terized by progressive neurospatial spread of pathology 
among motor neurons, and recently the transfer of extracel- 
lular, aggregated mutant SOD1 between cells was demon- 
strated in culture. however, there is currently no evidence 
that uptake of SOD1 into cells initiates neurodegenerative 
pathways reminiscent of aLS pathology. Similarly, whilst 
dysfunction to the eR–Golgi compartments is increasingly 
implicated in the pathogenesis of both sporadic and famil- 
ial aLS, it remains unclear whether misfolded, wildtype 
SOD1  triggers  eR–Golgi  dysfunction.  In  this  study  we 
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show that both extracellular, native wildtype and mutant 
SOD1  are  taken  up  by  macropinocytosis  into  neuronal 
cells. hence  uptake does not depend on SOD1 mutation 
or misfolding. We also demonstrate that purified mutant 
SOD1 added exogenously to neuronal cells inhibits pro- 
tein transport between the eR–Golgi apparatus, leading to 
Golgi fragmentation, induction of eR stress and apoptotic 
cell death. Furthermore, we show that extracellular, aggre- 
gated, wildtype SOD1 also induces eR–Golgi pathology 
similar to mutant SOD1, leading to apoptotic cell death. 
hence extracellular misfolded wildtype or mutant SOD1 
induce dysfunction to eR–Golgi compartments charac- 
teristic of aLS in neuronal cells, implicating extracellular 
SOD1 in the spread of pathology among motor neurons in 
both sporadic and familial aLS. 
 
Keywords extracellular · SOD1 · aLS · endoplasmic 
reticulum · Golgi 
 
 
 
Introduction 
 
amyotrophic lateral sclerosis (aLS) is a neurodegenerative 
disorder with focal onset followed by progressive spread 
throughout surrounding upper and lower motor neurons. 
the intercellular transfer of misfolded proteins has recently 
been demonstrated in several neurodegenerative diseases, 
including aLS  [1–3], and it has been suggested that this 
mechanism is responsible for the progressive spread of 
pathology. Mutations in SOD1 (Cu/Zn-superoxide dis- 
mutase) cause 20 % of familial aLS, and these cases dis- 
play similar clinical features and pathogenesis to sporadic 
aLS, which accounts for 90 % of all aLS cases. Misfolded 
and aggregated SOD1 is present in both familial and spo- 
radic aLS,  but its pathobiology remains unclear [4,  5]. 
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however, endoplasmic reticulum (eR) stress and fragmen- 
tation of the Golgi apparatus are well-described features 
in human aLS  patients as well as in animal and cellular 
disease models [6–9]. eR stress is triggered initially in the 
most vulnerable motor neurons during early disease stages 
in several lines of transgenic mutant SOD1 mice, thus 
implying an active role in neurodegeneration [8]. 
Wildtype SOD1 (SOD1Wt)  misfolds upon pathogenic 
triggers such as oxidative stress, and misfolded SOD1Wt 
exhibits similar toxic properties to mutant SOD1 [4]. 
Oxidized, misfolded SOD1Wt  is present in the intracellu- 
lar inclusions in motor neurons of sporadic aLS  patients 
[5,  10].  Furthermore,  recently  it  was  shown  that  trans- 
genic  overexpression  of  SOD1Wt   causes  aLS  in  mice 
[11]. together these data suggest that misfolded SOD1Wt 
could play a similar role to mutant SOD1 in the pathogen- 
esis of sporadic aLS. there is accumulating evidence that 
secreted,  extracellular  SOD1,  which  is  misfolded  either 
due to mutation or cellular stress, could be a toxic fac- 
tor spreading neurodegeneration among motor neurons in 
aLS. SOD1 is secreted by neuronal cells [12, 13] and is 
present in the cerebrospinal fluid (CSF) of aLS  patients 
[14, 15]. aggregated mutant SOD1 can be taken up by cells 
via macropinocytosis which triggers subsequent aggrega- 
tion of natively folded SOD1 [1]. Similarly, extracellular 
misfolded SOD1Wt induces cell death [16] and overex- 
pression of SOD1Wt  induces misfolding of natively folded 
SOD1 in human but not mouse neuronal cell lines, dem- 
onstrating species specificity in the transfer of misfolding 
[17]. Furthermore, therapeutic strategies targeting extracel- 
lular SOD1 using antibodies specific to misfolded SOD1, 
delay disease progression in mutant SOD1 transgenic mice 
[18–20]. however, there is currently no evidence to show 
that uptake of extracellular misfolded SOD1 into neuronal 
cells initiates neurodegenerative pathways reminiscent of 
aLS pathology. It also remains unclear if both natively 
folded and misfolded forms of SOD1Wt  and mutant SOD1 
can be taken up by neurons. 
eR stress triggers the unfolded protein response (UPR), 
a set of signaling pathways that activate sensor proteins 
including inositol requiring kinase 1 (IRe1), activating 
transcription factor 6 (atF-6) and x-box binding protein 1 
(Xbp1) [21]. activation  of UPR leads to down-regulation 
of general protein expression and upregulation of specific 
eR chaperones including immunoglobulin binding protein 
(BiP)  and  protein  disulfide isomerase  (PD1).  BiP  plays 
a key role in regulating induction of eR stress [22]. this 
leads to the upregulation and activation of IRe1, which 
mediates the splicing of Xbp1. Whilst initially protective, 
prolonged eR stress initiates apoptosis by activating ChOP 
(C/eBP homologous protein) [21], a transcription factor 
which translocates to the nucleus upon activation. Whilst 
eR stress is now recognized as an important pathogenic 
feature of aLS, the mechanism by which mutant SOD1 
activates the UPR is not fully defined, but includes bind- 
ing of mutant SOD1 to Derlin-1 at least by symptom onset 
in transgenic SOD1 mice [22]. Conventionally eR stress is 
triggered when misfolded proteins accumulate within eR, 
but SOD1 is predominately cytoplasmic [23]. however, eR 
stress can also be triggered by inhibition of protein trans- 
port between eR and Golgi apparatus [24, 25]. Inhibition 
of eR–Golgi transport implies disruption to the secretory 
pathway, and Golgi fragmentation is another pathological 
feature of aLS, observed in both human patients and cellu- 
lar and animal disease models [9, 26]. Likewise, the Golgi 
apparatus can fragment due to defects in eR to Golgi traf- 
ficking [27]. 
In this study, we examined whether extracellular, mis- 
folded SOD1Wt and mutant G93a SOD1 (SOD1G93a) 
activate  cellular  events  characteristic  of  aLS   pathol- 
ogy after uptake into neurons. aggregated  SOD1Wt  and 
SOD1G93a   proteins  were  taken  up  into  mouse  NSC-34 
and human Sh-SY5Y neuronal cells, leading to eR stress, 
Golgi fragmentation, and inhibition of eR–Golgi protein 
trafficking. apoptotic  cell  death  was  also  triggered  in 
Sh-SY5Y  cells.  Furthermore,  natively  folded  SOD1Wt 
was  taken  up  by  both  cell  lines,  demonstrating  that 
uptake is not specific to mutation or misfolding of SOD1. 
hence extracellular misfolded SOD1Wt and SOD1G93a 
induce cellular pathology characteristic of aLS,  provid- 
ing evidence for cell-to-cell transfer of SOD1 mediated 
neurotoxicity. 
 
 
 
Results 
 
Uptake of extracellular SOD1Wt and SOD1G93a 
by neuronal cells 
 
In order to examine the cell-to-cell propagation of SOD1, 
we first analyzed the uptake of extracellular SOD1 by 
mouse (NSC-34) motor neuron-like cell lines. Wildtype 
human SOD1 (SOD1Wt)  and aLS-linked  human mutant 
SOD1G93a proteins were expressed in bacteria and puri- 
fied to homogeneity as previously described [28]. Both 
proteins were metallated to the extent that they were enzy- 
mically active [28]. each protein was labeled with alexa 
Fluor 488 dye and then added to the culture medium of 
NSC-34 cells at a concentration of 2 µg/mL. Using fluo- 
rescence microscopy, the uptake of both labeled SOD1Wt 
and SOD1G93a was observed after 48 h (Fig. 1a), dem- 
onstrating that both SOD1Wt and mutant SOD1 can be 
taken up by neuronal NSC-34 cells. the formation of 
prominent inclusion-like structures was detected specifi- 
cally after uptake of extracellular mutant SOD1 but not 
SOD1Wt    in  NSC-34  cells.  Furthermore,  inhibitors  of 
Extracellular wildtype and mutant SOD1 induces ER–Golgi pathology  
 
 
macropinocytosis [5-(N-ethyl-N-isopropyl)amiloride (eIPa) 
and rottlerin] blocked the uptake of both SOD1Wt and 
SOD1G93a by NSC-34 cells, in contrast to inhibitors of 
clathrin mediated endocytosis [genistein and chlorproma- 
zine  hydrochloride  (CPZ);  Fig.  S1]. this  suggests  that 
both SOD1Wt and SOD1G93a are taken up by macropi- 
nocytosis into NSC-34 cells, as previously reported for 
aggregated mutant SOD1 [1]. 
We then examined the uptake of extracellular SOD1 
prepared  in  a  mammalian  baculovirus  expression  sys- 
tem. We transiently expressed GSt-tagged SOD1Wt and 
SOD1G93a  in Sf9 insect cells, which resulted in secretion 
of SOD1 into the medium due to the presence of the aKh 
signal  peptide  [29].  expression  and  secretion  of  SOD1 
was confirmed at 48 h post-transfection by immunoblot- 
ting of the conditioned Sf9 medium with an anti-GSt 
antibody (Fig. S2a). Furthermore, zymography confirmed 
that both mutant and SOD1Wt  retained enzymatic activ- 
ity in the conditioned media, demonstrating that both 
proteins were in their metallated, native form (Fig. S2B). 
the Sf9 conditioned media was then applied to untrans- 
fected NSC-34 cells for 48 h. Immunocytochemistry using 
an anti-GSt antibody revealed that GSt-tagged SOD1Wt 
and SOD1G93a  were taken up by NSC-34 cells (Fig. 1b). 
however,  there was  no  uptake  in  NSC-34  cells  treated 
with  conditioned  medium  from  insect  cells  expressing 
GSt  only, demonstrating that there was some specificity 
in the uptake for SOD1. In cells treated with SOD1Wt con- 
ditioned medium, the fluorescence was uniform and dis- 
persed throughout the cells. however, in cells treated with 
mutant SOD1G93a, prominent fluorescent structures remi- 
niscent of inclusions were present (Fig. 1b). hence both 
natively folded SOD1Wt and SOD1G93a present in insect 
cell conditioned media were taken up by NSC-34 cells, 
and the uptake of SOD1G93a  resulted in the formation of 
intracellular SOD1 inclusions. 
 
Uptake of extracellular recombinant mutant SOD1 
activates eR stress in mouse NSC-34 cells 
 
We next examined whether the uptake of extracellular 
mutant SOD1 activates eR stress in NSC-34 cells. We first 
examined whether the early phase of the UPR is activated 
in cells treated with extracellular SOD1. Immunoblotting 
for UPR markers IRe1, BiP and Xbp1 revealed an upreg- 
ulation of all three proteins in cells treated with mutant 
SOD1G93a compared to untreated cells or those treated with 
SOD1Wt  (Fig. 1c, d; threefold, P < 0.01). hence the early 
phases of UPR are induced in cells treated with extracellu- 
lar mutant SOD1G93a. We then examined cells for the later, 
pro-apoptotic phase of UPR using immunocytochemistry 
for nuclear ChOP [30, 31]. after 72 h treatment, a sig- 
nificant increase in nuclear ChOP  immunoreactivity was 
observed in NSC-34 cells treated with SOD1G93a compared 
to untreated and SOD1Wt  treated cells (Fig. 1e, f; twofold, 
P < 0.001). hence  the pro-apoptotic phase of UPR was 
also triggered in mutant SOD1 treated cells. these find- 
ings were confirmed in NSC-34 cells treated with Sf9 cell 
conditioned media. a significant upregulation in nuclear 
ChOP immunoreactivity was detected on treatment with 
Sf9 medium from SOD1G93a  expressing cells compared to 
SOD1Wt and GSt alone expressing cells (Fig. 1g; twofold, 
P < 0.001). hence the uptake of extracellular mutant SOD1 
expressed in either bacterial or a baculovirus system spe- 
cifically induces eR stress, including pro-apoptotic ChOP, 
in NSC-34 cells. 
 
Uptake of extracellular aggregated SOD1Wt and SOD1G93a 
by Sh-SY5Y human neuronal cells 
 
We next asked whether uptake of aggregated/misfolded 
SOD1Wt   could  induce  aLS-like  pathology  in  neuronal 
cells. For this purpose a human neuroblastoma cell line 
(Sh-SY5Y) was used due to the previously reported spe- 
cies specificity in seeding SOD1Wt  aggregation [17]. 
aggregated recombinant SOD1Wt and mutant SOD1G93a 
proteins were prepared by treatment with 5 mM eDta 
and 50 mM Dtt  to remove metal ions and reduce the 
native Cys57-Cys146 SOD1 disulfide bond, respectively, 
as described previously [28, 32–34]. the  aggregated pro- 
teins (aggSOD1Wt, aggSOD1G93a) and native SOD1Wt and 
SOD1G93a were then labeled with alexa Fluor 488 dye. 
Silver staining of non-denaturing native gel and denaturing 
SDS-PaGe gel revealed that both SOD1Wt  and SOD1G93a 
formed  SDS-stable  high  molecular  weight  aggregates 
(Fig. 2a, b). 
Labeled aggSOD1Wt  and aggSOD1G93a,  and unaggre- 
gated SOD1Wt and SOD1G93a for comparison were then 
added to the culture medium of Sh-SY5Y cells at a con- 
centration of 2 µg/mL. Fluorescence microscopy revealed 
that 48 h after treatment, Sh-SY5Y cells had taken up both 
aggregated and unaggregated SOD1Wt and SOD1G93a from 
the culture medium (Fig. 2c). Differential interference con- 
trast (DIC) microscopy revealed the formation of membrane 
ruffles in all cases, consistent with a macropinocytosis 
mechanism for uptake of SOD1, as previously reported 
for mutant SOD1 aggregates [1] (Fig. 2c). In cells treated 
with SOD1G93a, aggSOD1Wt  and aggSOD1G93a  intracellu- 
lar fluorescent inclusions were formed (20–30 % of cells; 
Fig. 2d). Surprisingly, in a small proportion of cells (7 %) 
treated with unaggregated native SOD1Wt, inclusions were 
also present (Fig. 2d), which were never observed in murine 
NSC-34 cells (Fig. 1a, b). Intracellular higher molecular 
weight SOD1 aggregates were also present in cell lysates, 
which were harvested after 0.125 % trypsin treatment of 
the cells, to digest residual extracellular SOD1 aggregates 
V. Sundaramoorthy et al.  
 
 
 
 
 
(Fig. 2e). endogenous  human SOD1 was clearly present 
in untreated cells (Fig. 2e). however,  in all cells treated 
with extracellular SOD1, reduced levels of endogeneous 
SOD1 was observed, and a corresponding increase in the 
levels of high molecular weight aggregates was detected. 
this finding implies that recruitment of endogenous SOD1 
into higher molecular weight aggregates has occurred in 
cells treated with aggregated SOD1Wt  and mutant SOD1. 
also, consistent with the microscopy findings, in unaggre- 
gated SOD1Wt  treated cell lysates, SOD1 aggregates were 
observed, although these aggregates ran at a faster mobil- 
ity than those formed by mutant SOD1, suggesting they 
Extracellular wildtype and mutant SOD1 induces ER–Golgi pathology  
 
 
◂ Fig. 1  Uptake of extracellular mutant SOD1G93a triggers eR stress in 
mouse NSC-34 cells. a Recombinant SOD1Wt  and SOD1G93a  (2 µg/ 
mL) labeled with alexa Fluor 488 dye (green) are taken up by NSC-34 
cells 48 h after addition to medium. Nuclei are stained with DaPI 
(blue). White arrows show the formation of inclusion-like structures 
in cells treated with extracellular SOD1G93a. b extracellular GSt- 
tagged SOD1Wt  and SOD1G93a  (GSt-SOD1Wt, GSt-SOD1G93a) are 
taken up by NSC-34 cells. Insect cell (Sf9) conditioned medium con- 
taining GSt-SOD1Wt, GSt-SOD1G93a  or GSt only control (100 µg 
total protein) was added to NSC-34 cells for 48 h. Cells were then 
fixed and immunostained with anti-GSt antibody (green). No immu- 
noreactivity was observed in cells treated with GSt alone (GSt) in 
contrast to GSt-SOD1 treated cells. White arrow shows the forma- 
tion  of  inclusion-like  structures  in  cells  treated  with  extracellular 
GSt-SOD1G93a. c Immunoblotting reveals upregulation of UPR 
markers IRe1, BiP, and spliced Xbp1 in NSC-34 cells 72 h after 
treatment with recombinant purified SOD1G93a,  in contrast to cells 
Wt
 
treated with unaggregated SOD1Wt  compared to untreated 
cells. Similarly, using immunocytochemistry, a significant 
increase in nuclear ChOP in Sh-SY5Y cells treated with 
SOD1G93a, aggSOD1Wt and aggSOD1G93a treated cells 
compared to untreated cells was detected (Fig. 3c, d; three- 
fold, P < 0.001). hence uptake of extracellular aggregated 
SOD1 induces the eR stress-specific pro-apoptotic phase of 
UPR in Sh-SY5Y cells, similar to mutant SOD1. Consist- 
ent with the immunoblotting results, we observed a modest 
but significant increase in nuclear ChOP immunoreactivity 
in cells treated with unaggregated SOD1Wt (P < 0.05) com- 
pared to untreated cells. In contrast, neither bacterial nor 
baculovirus SOD1Wt induced eR stress in NSC-34 cells 
(Fig. 1c). hence extracellular, native SOD1Wt  induces eR 
treated with recombinant SOD1 and untreated (Ut) cells (20 µg/ 
stress in the Sh-SY5Y human cell line but not the NSC-34
 
lane). as  a positive control NSC-34 cells were treated with 10 µM 
thapsigargin to induce eR stress (thaPS) for 1 h before lysis. β-actin 
was used as a loading control. d Densitometric analysis of the immu- 
noblots relative to β-actin intensity confirms upregulation of all three 
UPR markers in NSC-34 cells treated with recombinant SOD1G93a. 
e Representative images showing increased nuclear immunoreactiv- 
ity to pro-apoptotic, eR stress-specific ChOP (red) in NSC-34 cells 
treated with SOD1G93a  for 72 h. Nuclei are stained with DaPI (blue). 
f Quantification of NSC-34 cells containing nuclear immunoreactiv- 
ity to ChOP  72 h after treatment with recombinant, purified SOD1 
(SOD1Wt,  SOD1G93a)  and untreated cells (Ut).  g Quantification of 
NSC-34 cells containing nuclear immunoreactivity to ChOP  72 h 
after treatment with Sf9 insect cell conditioned medium containing 
GSt-SOD1 (GSt-SOD1Wt, GSt-SOD1G93a) or GSt alone. Results 
are expressed as mean ± SeM; n = 3; **P < 0.01, ***P < 0.001 ver- 
sus SOD1Wt  and untreated cells (Ut) (f) or SOD1Wt  or GSt treated 
cells (g) as indicated by one-way aNOVa  with tukey’s  post-test, 
n = 3. all scale bars represent 10 µm 
 
 
 
are smaller than those in other cell populations. hence 
misfolded/aggregated  SOD1Wt    and  mutant  SOD1  are 
taken up by human neuronal cells, leading to intracellular 
SOD1 aggregation and possible recruitment of endogenous 
SOD1. Induction of SOD1 aggregation by natively folded 
SOD1Wt was also detected in a small proportion of cells. 
 
Uptake of extracellular aggregated SOD1Wt and SOD1G93a 
activates eR stress in Sh-SY5Y cells 
 
We  next  examined  whether  eR  stress  is  activated  in 
Sh-SY5Y cells treated with extracellular SOD1G93a, 
aggSOD1Wt and aggSOD1G93a for 72 h. Immunoblotting 
for IRe1,  BiP and spliced Xbp1, revealed that the UPR 
was induced (Fig. 3a, b; twofold, P < 0.01) in Sh-SY5Y 
cells treated with aggregated and unaggregated SOD1G93a 
compared  to  untreated  cells,  consistent  with  the  find- 
ings in NSC-34 cells. Furthermore, in cells treated with 
aggSOD1Wt, induction of the UPR was also observed, 
demonstrating  that  SOD1Wt   can  also  trigger  eR stress 
when misfolded. Surprisingly we also observed a slight 
but significant upregulation of Xbp1 (P < 0.05) in cells 
 
mouse neuronal cell line. 
 
extracellular aggregated SOD1Wt and SOD1G93a inhibits 
eR to Golgi protein trafficking and induces Golgi 
fragmentation 
 
We next examined whether extracellular misfolded or 
mutant SOD1 could also inhibit eR to Golgi protein traf- 
ficking. Vesicular stomatitis virus glycoprotein ts045 
(VSVG-ts045) is a widely employed marker used to exam- 
ine eR–Golgi transport [35]. VSVG-ts045 misfolds and is 
retained in the eR at 40 °C, but is transported to the Golgi 
apparatus at the permissive temperature of 32 °C [35]. 
We first examined eR–Golgi transport in Sh-SY5Y cells 
transfected with SOD1 proteins linked to eGFP [6, 12] and 
VSVG-ts045 mCherry, to confirm that intracellular mutant 
SOD1 can inhibit eR–Golgi  trafficking in this cell line. 
VSVG-ts045 was detected immunocytochemically using 
markers of the eR (calnexin) and Golgi (GM130) and its 
co-localization with each marker was quantified using 
Mander’s coefficient [36]. at 32 °C, VSVG-ts045 was 
transported to the Golgi in untransfected cells and in cells 
expressing SOD1Wt (Fig. S3a). however, in cells express- 
ing mutant SOD1 (Fig. S3a) most VSVG-ts045 remained 
in the eR and significantly less (~50 %) was transported 
to the Golgi (Fig. S3B; P < 0.01). hence eR–Golgi traf- 
ficking is inhibited by intracellular mutant SOD1 in the 
Sh-SY5Y cell line (Fig. S3a, S3B). We next examined 
eR–Golgi transport in cells treated with extracellular SOD1 
proteins. Sh-SY5Y cells were transiently transfected with 
VSVG-ts045 mCherry. at  24 h post-transfection, 2 µg/ 
mL of purified, labeled SOD1Wt, SOD1G93a, aggSOD1Wt 
and aggSOD1G93a  were added to the Sh-SY5Y  medium 
for another 48 h. transport of VSVG-ts045 from the eR to 
Golgi was then examined using immunocytochemistry to 
calnexin and GM130 as above. Quantification of the degree 
of co-localization of VSVG-ts045 with eR and Golgi com- 
partments using Mander’s coefficient was then performed. 
V. Sundaramoorthy et al.  
 
 
 
 
VSVG-ts045 was efficiently transported to the Golgi appa- 
ratus in untreated cells after 60 min at 32 °C. however, 
in cells treated with extracellular SOD1G93a, aggSOD1Wt 
or aggSOD1G93a, VSVG-ts045 was retained in the eR and 
significantly less was transported to the Golgi (P < 0.001) 
compared to untreated cells (Fig. 4a–c). hence extracel- 
lular mutant SOD1 inhibits eR–Golgi transport similar to 
intracellular mutant SOD1. these findings were confirmed 
using NSC-34 cells treated with extracellular SOD1G93a 
(Fig.  4d).  Furthermore,  aggSOD1Wt   also  inhibited  eR 
to Golgi protein trafficking in Sh-SY5Y  cells, to a level 
comparable to both SOD1G93a and aggSOD1G93a. hence 
both mutant and aggregated SOD1 inhibit eR–Golgi trans- 
port. there  was no significant difference in the transport 
of VSVG-ts045 from eR–Golgi in NSC-34 cells treated 
with native SOD1Wt  compared to Ut  cells. a slight dif- 
ference  was  observed  in  Sh-SY5Y  cells  treated  with 
native SOD1Wt,  but this was not statistically significant 
Extracellular wildtype and mutant SOD1 induces ER–Golgi pathology  
 
 
◂ Fig. 2  Uptake  and  aggregation  of  extracellular  mutant  SOD1G93a 
and aggregated SOD1Wt   in Sh-SY5Y  cells. a Recombinant puri- 
fied SOD1Wt  and SOD1G93a  proteins were aggregated by treatment 
with 50 mM Dtt  and 5 mM eDta  at 37 °C for 72 h and labeled 
with alexa Fluor 488 dye. the formation of aggregates was con- 
firmed by 10 % native gel electrophoresis (1 µg/lane) followed by 
silver  staining.  b  Silver  stained  SDS  PaGe  of  SOD1  aggregates 
with 100 mM Iodoacetamide, revealed the presence of SDS stable 
higher molecular weight Wtagg488 and G93aagg488 aggregates, as 
indicated. c Native and aggregated SOD1Wt and SOD1G93a labeled 
proteins were added to the Sh-SY5Y cell culture medium at a con- 
centration of 2 µg/mL. after 48 h treatment, the cells were fixed and 
488
 
Uptake of extracellular aggregated SOD1Wt or mutant 
SOD1 induces cell death in Sh-SY5Y cells 
 
Prolonged eR stress and induction of ChOP  implies that 
apoptotic cell death is triggered in cells treated with extra- 
cellular SOD1. hence we next examined induction of apop- 
tosis using annexin V/propidium iodide (PI) staining by 
flow cytometry [37]. after 72 h treatment with extracellular 
SOD1, apoptotic cell death was quantified using FaCS. In 
Sh-SY5Y cells there was a significant increase (P < 0.05) 
examined by fluorescence microscopy (SOD1 , green), after stain- 
in the percentage of cells undergoing apoptosis after treat-
 
ing the nuclei with DaPI  (blue). Representative images show the 
uptake of extracellular protein in each case. Intracellular fluorescent 
SOD1 inclusions were abundant in mutant SOD1 and aggregated 
SOD1 treated cells, and were present in a small proportion of native 
Wt
 
 
ment with aggSOD1Wt, SOD1G93a and aggSOD1G93a com- 
pared to untreated cells (Fig. 6a, b). treatment with aggre- 
gated forms of SOD1Wt  and SOD1G93a  induced apoptosis 
SOD1 treated cells. DIC images (panel 3 from left, white arrows) 
in a higher percentage of cells compared to the respective
 
show the formation of membrane ruffles characteristic of macropino- 
cytosis in each case. all scale bars represent 10 µm. d Quantification 
of SOD1 inclusion formation in Sh-SY5Y cells 48 h after treatment 
(Ut, SOD1Wt, SOD1G93a, SOD1Wtagg, SOD1G93aagg). SOD1 inclu- 
sions were defined as fluorescent, inclusion-like structures greater 
than 1 µm in diameter and were quantified using ImageJ. Results are 
 
native forms (P < 0.05). hence apoptosis is triggered by 
extracellular misfolded SOD1 proteins in Sh-SY5Y cells. 
however, there were no significant differences in the per- 
centage of cells undergoing apoptosis in NSC-34 cells after 
expressed as mean ± SeM; n = 3; **P < 0.01, ***P < 0.001 versus treatment with extracellular SOD1
Wt  and SOD1G93a  com- 
Ut  by one-way aNOVa  with tukey’s  post-test. e Following extra- 
cellular protein treatment for 48 h, Sh-SY5Y cell lysates were col- 
lected after 0.125 % trypsin digestion of cells to remove the residual 
extracellular SOD1 inoculum and run on 10 % native PaGe. high 
molecular weight intracellular SOD1 aggregates were present in all 
lysates except Ut cells as indicated. endogeneous human Sh-SY5Y 
SOD1 can be seen in Ut, but this band is reduced in cells treated with 
Wt
 
pared to the controls (Fig. 6c). 
 
 
 
Discussion 
 
this  study  provides  clear  evidence  that  the  uptake  of 
native SOD1 , indicating the recruitment of endogenous SOD1 into 
extracellular misfolded SOD1 into neuronal cells initiates
 
the high molecular weight aggregates. Similarly, this band is further 
decreased in cells treated with G93a, Wtagg  and G93aagg  compared 
to both Ut and SOD1Wt 
 
 
 
(Fig. 4a–c). Consistent with these findings, extracellular 
mutant SOD1 did not co-localise with eR markers after 
uptake into NSC-34 cells (Fig S4). hence these data sug- 
gest that extracellular SOD1 triggers eR stress from the 
cytoplasm following uptake into neuronal cells, by inhib- 
iting the transport of secretory proteins from the eR to 
Golgi. 
Inhibition of eR–Golgi  transport implies disruption to 
the secretory pathway. hence fragmentation of the Golgi 
apparatus was next examined in Sh-SY5Y  cells treated 
with extracellular SOD1, by immunostaining with anti- 
GM130 antibody. In untreated cells the Golgi apparatus 
mostly localized to a compact, perinuclear ribbon. In con- 
trast, the Golgi apparatus fragmented into condensed punc- 
tate structures in 25–40 % of cells treated with SOD1G93a, 
aggSOD1Wt   and  aggSOD1G93a   (Fig.  5a,  c).  Similarly, 
Golgi fragmentation was also detected in 25 % of NSC- 
34 cells treated with extracellular SOD1G93a  (Fig. 5b, d; 
P < 0.05). the Golgi was fragmented in a smaller but sig- 
nificant percentage of Sh-SY5Y  cells (P < 0.05) treated 
with native SOD1Wt, but not in NSC-34 cells treated with 
native SOD1Wt (Fig. 5c, d). 
 
neurodegenerative pathways reminiscent of aLS pathol- 
ogy. Misfolded SOD1Wt  and mutant SOD1 were taken up 
by neuronal cells, inducing the formation of intracellular 
SOD1-positive inclusions. this triggered inhibition of trans- 
port from the eR to Golgi apparatus, eR stress, fragmen- 
tation of the Golgi and neuronal cell death, implying that 
extracellular SOD1 may be responsible for the spread of 
neurodegeneration among motor neurons in aLS.  Moreo- 
ver, both mutant SOD1 and aggregated SOD1Wt  displayed 
a similar ability to induce these effects, thus providing clues 
into the pathology of both familial and sporadic aLS. 
this study also demonstrates that the uptake of extra- 
cellular SOD1 does not depend on the presence of a 
mutation  or  aggregation.  extracellular   SOD1Wt    was 
taken up by murine NSC-34 cells, which did not induce 
pathology. a previous study demonstrated that extracel- 
lular, aggregated mutant SOD1 is taken up by macropi- 
nocytosis, a mechanism of non-selective endocytosis of 
macromolecules from the extracellular space [1]. the 
findings of  our  study  are  consistent  with  this  mecha- 
nism because both natively folded and aggregates of 
SOD1Wt and mutant SOD1 were taken up to a similar 
degree. also, inhibitors of macropinocytosis were able to 
block the uptake of SOD1Wt  and SOD1G93a  into NSC- 
34 cells. Furthermore, membrane ruffles characteristic of 
macropinocytosis were present in Sh-SY5Y  cells after 
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Fig. 3  Uptake  of  extracellular,  aggregated  SOD1Wt    and  mutant 
SOD1 activates eR stress in Sh-SY5Y  cells. a Immunoblotting of 
cell lysates from Sh-SY5Y cells treated with extracellular proteins 
SOD1G93a, Wtagg, and G93aagg  reveals upregulation of UPR markers 
IRe1, BiP, and spliced Xbp1 after 72 h treatment (20 µg/lane). as a 
positive control, cells were treated with 10 µM thapsigargin (thaPS) 
for 1 h before lysis to induce eR stress. β-actin was used as a load- 
ing control. b Densitometric quantification of immunoblots relative to 
β-actin intensity reveals upregulation of all three UPR markers in cells 
treated with SOD1G93a, Wtagg, and G93aagg  compared to Ut cells. 
Results are expressed as mean ± SeM; n = 3; *P < 0.05, **P < 0.01, 
***P < 0.001 versus untreated cells or SOD1Wt  treated cells as indi- 
cated, by one-way aNOVa with tukey’s post-test. c Representative 
fluorescent microscopy images demonstrate nuclear immunoreac- 
tivity to ChOP (red), indicating activation of ChOP and hence eR 
stress, 72 h after treatment with Wt, G93a, Wtagg, G93aagg  SOD1. 
all scale bars represent 10 µm. d Quantification of the proportion of 
Sh-SY5Y  cells with nuclear ChOP  immunoreactivity in (c), 72 h 
after treatment with Wt, G93a, Wtagg and G93aagg. Results are 
expressed as mean ± SeM; n = 3; *P < 0.05, ***P < 0.001 versus 
Ut by one-way aNOVa with tukey’s post-test 
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treatment  with  extracellular  SOD1  [38–40].  Our  find- 
ings imply that secretion or simple diffusion of misfolded 
SOD1 into CSF by affected cells (including astrocytes 
and microglia, as well as motor neurons) could be subse- 
quently endocytosed by neighboring motor neurons, thus 
inducing neurodegeneration. as aLS  is now considered 
as a multi-system disorder where there is an interplay 
between motor neurons and other neuronal cell types [41, 
42], uptake of misfolded or mutant SOD1 by neuronal 
cells would therefore explain the neurospatial spread of 
pathology in human aLS. Consistent with this notion, 
misfolded SOD1 has been identified in the CSF of spo- 
radic and familial aLS  patients [14, 15]. even  low lev- 
els of misfolded SOD1 in CSF could seed intracellular 
aggregation after uptake [14], subsequently spreading 
pathology. 
aggregated forms of SOD1Wt  induced similar cellular 
pathogenic effects to mutant SOD1 in this study. Further- 
more, we observed the formation of inclusions in a small 
proportion of Sh-SY5Y cells treated with native SOD1Wt, 
which were never present in NSC-34 cells. Metal-free 
forms of SOD1 have been proposed to be the toxic pre- 
cursor preceding aggregation in familial aLS [43, 44]. the 
majority of aLS mutations affect the structural stability of 
SOD1, leading to the exposure of buried hydrophobic resi- 
dues, thus resulting in aggregation [45]. hence SOD1Wt 
has an intrinsic propensity to aggregate which is enhanced 
by mutation. Previous studies have demonstrated that 
misfolded, oxidized SOD1Wt is as pathogenic as mutant 
SOD1 [16]. however, we observed pathological effects 
induced by extracellular native SOD1Wt in human Sh- 
SY5Y cells not previously observed in murine NSC-34 
cells or by intracellular expression of SOD1Wt. the reason 
for this is unclear, but it is possible that native SOD1Wt 
recruits endogeneous human SOD1 into aggregates after 
uptake in Sh-SY5Y  cells. this  would explain the lower 
but significant inclusion formation, activation of eR stress 
and Golgi fragmentation in Sh-SY5Y cells treated with 
unaggregated, extracellular SOD1Wt. Both recombinant, 
purified SOD1Wt  from Escherichia coli, or Sf9 medium 
containing SOD1Wt, were taken up by NSC-34 cells, but 
neither induced eR stress, or aggregate/inclusion forma- 
tion. Similarly, we detected apoptosis in Sh-SY5Y  cells 
but  not  NSC-34  cells  treated  with  extracellular  SOD1. 
these data are consistent with the notion that there is spe- 
cies  specificity in  the  recruitment  of  SOD1  misfolding 
[17], thus implicating a gain of toxic function by SOD1Wt 
in the presence of human SOD1. Indeed, overexpression of 
SOD1Wt  induces misfolding of endogenous SOD1 in the 
same cell line [17]. We also observed that the addition of 
extracellular SOD1 results in the rapid formation of intra- 
cellular SOD1 aggregates in the cytoplasm after uptake. 
this  replicates the commonly described observation that 
over-expression  of  mutant  SOD1  in  cell  culture  results 
in the rapid formation of aggregates. In contrast, aggre- 
gates appear much later in mouse aLS  models based on 
transgenic over-expression of mutant SOD1, generally at 
the end stages of disease [11, 46], thus highlighting dif- 
ferences observed between animal and cellular disease 
models. 
eR stress is now established as a key pathway to cell 
death in aLS  [7, 8, 23, 31]. Mutant SOD1 induces eR 
stress [6] and Golgi fragmentation [26] in neuronal cell 
cultures, and we now show that aggregated SOD1Wt 
induces UPR and Golgi fragmentation similar to mutant 
SOD1. these findings are consistent with recent evidence 
for  common  pathogenic  pathways  shared  by  mutant 
SOD1 and SOD1Wt, and the presence of misfolded 
SOD1Wt  in sporadic aLS tissues [4, 5]. It is unclear how 
eR stress is triggered in aLS because SOD1 is normally 
located in the cytoplasm and reports that it is found in 
microsomes  [47]  have  been  subsequently  challenged 
[23]. however, it was previously proposed that eR stress 
in aLS is triggered by cytoplasmic SOD1 [23]. We show 
here that extracellular SOD1 does not co-localise with 
eR markers after uptake, consistent with the notion that 
eR stress is triggered from the cytoplasm. however, eR 
stress can be caused by failure of eR–Golgi trafficking 
[24, 25]. We also confirm here that intracellular mutant 
SOD1 inhibits the transport of VSVG-ts045 from the eR 
to Golgi in Sh-SY5Y cells, and we show that extracel- 
lular forms of mutant and aggregated SOD1Wt  also delay 
eR–Golgi traffic, thus providing one possible explanation 
for induction of eR stress. Similarly, Golgi fragmenta- 
tion is also triggered by an imbalance between antero- 
grade and retrograde traffic between eR and Golgi [26], 
highlighting a possible role for disruption to eR–Golgi 
traffic in both events. the activation of pro-apoptotic 
ChOP and increase in the proportion of cells undergoing 
apoptosis in cells treated with extracellular SOD1 pro- 
vides a link between extracellular proteins and neurode- 
generation and UPR-specific cell death. hence this study 
also provides further evidence linking the disruption of 
eR–Golgi compartments to aLS and shows that extracel- 
lular misfolded proteins can induce dysfunction in these 
organelles. 
In conclusion, this study establishes mechanisms of 
toxicity induced by extracellular SOD1 applicable to both 
sporadic and familial aLS. Our findings are consistent with 
a prion-like propagation of neurotoxicity in aLS, and they 
provide further evidence for common neurodegenerative 
pathways shared by mutant and SOD1Wt linked to the eR– 
Golgi compartments. the demonstration of specific, cel- 
lular pathways targeted by extracellular, misfolded SOD1 
also provides novel targets for ameliorating the spread of 
neurodegeneration in aLS. 
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Materials and methods 
 
expression and purification of recombinant SOD1 
 
human SOD1Wt  and SOD1G93a  were expressed and puri- 
fied from E. coli as previously described [28, 48]. Briefly, 
E. coli cells were cultured at 23 °C with 3 mM CuSO4 and 
30 µM ZnSO4 for metal loading. SOD1
Wt  and SOD1G93a 
proteins were then purified from bacterial lysates, by heat 
denaturation,  size  exclusion  chromatography  (Superdex 
75; Ge healthcare),  and anion-exchange chromatography 
using a Q-Sepharose anion exchange column (Ge health- 
care), and eluted with a salt gradient of 0–125 mM NaCl, 
ph 7.5 [28]. 
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◂ Fig. 4  Uptake of extracellular, aggregated Wt  and mutant SOD1 
inhibits eR to Golgi protein trafficking in Sh-SY5Y cells. Cells 
expressing VSVG-ts045 mCherry were treated with Wt, G93a, 
Wtagg, G93aagg at 24 h post transfection. after trapping VSVG- 
ts045 mCherry in the eR by incubation at 40 °C for 24 h, the tem- 
perature was shifted to 32 °C for 60 min or fixed immediately at 
0 min. the cells were then stained with calnexin (blue), a marker of 
the eR, or GM130 (blue), a marker of the Golgi apparatus. a Rep- 
resentative fluorescent images of cells expressing VSVG-ts045 (red) 
treated with Wt, G93a, Wtagg, G93aagg  SOD1 protein (green) and 
Ut cells after incubation at 40 °C (0 min). b Representative fluo- 
rescent images after 60 min incubation at 32 °C. VSVG is co-local- 
ised with GM130 in cells treated with native SOD1Wt  and Ut cells 
in contrast to cells treated with Wtagg, G93a, G93aagg, in which 
VSVG  is  still  predominantly  co-localised  with  calnexin,  indicat- 
ing an inhibition of VSVG-ts045 transport from eR to Golgi. all 
scale bars 10 µm. c Quantification of the degree of co-localisa- 
tion of VSVG-ts045 with calnexin and GM130 at 60 min as in b 
using Mander’s coefficient. Data are presented as mean ± 
SeM, 
***P < 0.001 versus Ut  by one-way aNOVa  with tukey’s  post- 
test, n = 3. d Uptake of extracellular mutant SOD1 inhibits eR to 
Golgi protein trafficking in NSC-34 cells. Cells expressing VSVG- 
ts045 mCherry were treated with recombinant, labelled SOD1Wt 
or SOD1G93a  at 24 h post transfection. after trapping VSVG-ts045 
mCherry in the eR by incubation at 40 °C for 24 h, the tempera- 
ture was shifted to 32 °C for 0 and 30 min. the degree of co-local- 
isation of VSVG-ts045 with calnexin and GM130 was quantified 
using Mander’s coefficient. Data are presented as mean ± SeM, 
***P < 0.001 versus SOD1Wt treated or Ut cells as indicated by 
one-way aNOVa with tukey’s post-test, n = 3 
 
expression of SOD1 from Sf9 baculoviral system 
 
human  SOD1Wt   and  SOD1G93a   constructs  were  gener- 
ated by PCR and cloned into pIeX-3 plasmids using SpeI 
restriction sites. Spodoptera frugiperda (Sf9) cells were 
kindly provided by Dr. Mark hulett, La trobe University. 
the cells were cultured at 28 °C and transfected using 
GeneJuice transfection reagent (Invitrogen) as per the 
manufacturer’s protocol. 48 h after transfection the culture 
medium was collected after centrifugation at 1200 rpm for 
5 min and analyzed by immunoblotting. 
Zymography–SOD1 activity assay 
For zymography, SOD1 protein samples were electrophoresed 
on a 10 % native PaGe. the gel was then soaked in 2.45 mM 
nitro blue tetrazolium (Sigma) for 20 min, washed with dh2O 
and soaked in developer solution containing 28 mM tetra- 
methylehylenediamine (teMeD; BIO-RaD), 28 µM ribo- 
flavin, and 36 mM Kh2PO4  (Sigma) for 15 min. the gel was 
illuminated for 5–15 min until sufficient contrast between ach- 
romatic zones and blue background was achieved. 
 
aggregation and labeling of SOD1Wt and mutant 
SOD1G93a 
 
In vitro SOD1 aggregation was performed as previously 
described [28]. Purified SOD1Wt and G93a SOD1 proteins 
(1 mg/mL) dissolved in PBS were incubated with 50 mM 
dithiothreitol (Dtt) and 5 mM ethylenediaminetetraacetic 
acid (eDta) at 37 °C for 72 h whilst shaking and vortexed 
briefly to obtain a homogenous solution. aggregated  and 
native SOD1Wt  and SOD1G93a  were then labeled using the 
alexa Fluor 488 Microscale Protein Labeling Kit (Invitro- 
gen). Protein (100 µg) was incubated with dye in the pres- 
ence of 100 mM NahCO3  at room temp for 15 min. the 
unlabeled protein was then separated using amicon  Ultra 
10 kDa centrifugal filters (Millipore). 
extracellular SOD1 treatment 
Mouse motor neuron-like NSC-34 or human neuroblastoma 
Sh-SY5Y cells were cultured on 24 well plates with or with- 
out 13 mm coverslips at 105 cells/well. Purified recombinant 
SOD1 (2 µg/mL) expressed in bacteria was added to the 
culture medium 24 h after seeding, and 48 h later the cells 
were analyzed by immunocytochemistry or immunoblotting. 
For cells treated with Sf9 conditioned medium containing 
GSt-SOD1 or GSt-only control, medium containing 100 µg 
total protein was added to the NSC-34 culture medium to a 
final concentration of 0.2 mg/mL. 
 
SOD1 uptake and inhibition 
 
NSC34 cells were cultured on coverslips for 24 h before 
treatment with either 3 µM rottlerin D, 100 µM eIPa, 
10 µM genistein or 5 µM chlorpromazine hCL for 30 min 
at 4 °C. these cells were then treated with SOD1Wt or 
SOD1G93a or untreated at 4 °C for 30 min before being 
washed with PBS. the cells were then fixed with 4 % PFa 
and incubated with 0.5 % BSa in PBS for 20 min at room 
temperature. a 1:500 dilution of anti-human SOD1 sheep 
antiserum  (thermo   Fisher  Scientific)  in  PBS  contain- 
ing 0.1 % BSa and subsequent goat anti-sheep alexa488 
(Invitrogen) was used to detect internalized SOD1. SOD1 
was visualized using a Leica SP5 scanning confocal 
microscope. 
 
Immunocytochemistry 
 
NSC-34 or Sh-SY5Y cells grown on coverslips were 
washed with PBS and fixed with 4 % paraformaldehyde 
(PFa; Merck) in PBS for 10 min. Cells were permeabilized 
in 0.1 % triton X-100 in PBS for 2 min, blocked for 30 min 
with 1 % BSa in PBS and incubated with the appropriate 
primary antibodies as follows for 16 h at 4 °C: anti-ChOP 
(1:50; Santa Cruz), anti-GM130 (1:50; BD transduction 
Laboratories™),  anti-Calnexin  (1:100;  abcam)  or  anti- 
GSt (MBB lab; La trobe University). Secondary alex- 
aFluor-594 or 644 conjugated anti-mouse or anti-Rabbit 
antibodies (1:2000; Molecular Probes) were incubated for 
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Fig. 5  Uptake  of  extracellular,  aggregated  SOD1Wt    and  mutant 
SOD1 induces Golgi fragmentation in Sh-SY5Y and NSC-34 cells. 
Sh-SY5Y cells treated with extracellular Wt, G93a, Wtagg, G93aagg 
SOD1 or NSC-34 cells treated with SOD1Wt and SOD1G93a were 
fixed with 4 % PFa  after 72 h treatment and immunostained with 
anti-GM130 antibody. a Representative images of Sh-SY5Y cells 
treated with Wt, G93a, Wtagg, G93aagg  SOD1 (green). Cells were 
stained  with  anti-GM130  antibody  (red)  and  nuclei  were  stained 
with DaPI (blue). Arrows indicate fragmented Golgi, indicated by 
condensed punctate structures in contrast to intact Golgi (Ut cells). 
b Representative images of NSC-34 cells stained with GM130 (red) 
showing fragmented Golgi after treatment with mutant SOD1G93a. all 
scale bars represent 10 µm. c Quantification of cells with fragmented 
Golgi  in  Sh-SY5Y  cells  upon  treatment  with  extracellular  Wt, 
G93a, Wtagg, G93aagg  SOD1 for 72 h. d Quantification of cells with 
fragmented Golgi in NSC-34 cells 72 h after treatment with extracel- 
lular SOD1Wt  and SOD1G93a.  there  is no significant difference in 
the proportion of NSC-34 cells with fragmented Golgi in extracellu- 
lar SOD1Wt treated cells compared to Ut cells, in contrast to Sh- 
SY5Y cells. Results are expressed as mean ± SeM; n = 3; *P < 0.05, 
**P < 0.01, ***P < 0.001 versus Ut cells by one-way aNOVa with 
tukey’s post-test 
 
 
1 h at room temperature, cells were then treated with hoe- 
chst 33342 (Invitrogen) and mounted on slides using fluo- 
rescent mounting medium (Dako). Images were acquired 
using constant gain and offset settings for ChOP using an 
Olympus fluorescence microscope at 40× magnification. 
Induction of eR stress was assessed by examining indi- 
vidual cells for nuclear immunoreactivity to ChOP. For 
each treatment, 100 cells from three different experiments 
were scored. Fragmentation of the Golgi apparatus was 
determined by staining with the anti-GM130 antibody. the 
number of cells with fragmented Golgi per 100 cells from 
three different experiments was scored by fluorescence 
microscopy. 
 
Protein extraction 
 
the cells were washed with PBS and lysed with tN buffer 
(50 mM tris–hCl ph 7.5, 150 mM NaCl, 0.1 % SDS) with 
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Fig. 6  Uptake of extracellular 
aggregated SOD1Wt and mutant 
SOD1 induces apoptotic cell 
death in Sh-SY5Y cells but 
not NSC-34 cells. a Sh-SY5Y 
cells treated with extracellular 
Wt, G93a, Wtagg and G93aagg 
SOD1 for 72 h were harvested, 
stained with PI/annexin V 
and the percentage of cells in 
both early and late apoptotic 
phase was gated and scored by 
flow cytometry, as indicated 
by cells stained with both PI 
and annexin V. b Percent- 
age of apoptotic cells among 
cells treated with Wt, G93a, 
Wtagg and G93aagg and Ut 
cells. Results are expressed as 
mean ± SeM; n = 3; *P < 0.05, 
**P < 0.01, ***P < 0.001 ver- 
sus untreated cells by one-way 
aNOVa with tukey’s post-test, 
n = 3. c NSC-34 cells treated 
with extracellular SOD1Wt and 
SOD1G93a for 72 h were stained 
with PI/annexin V and analysed 
by flow cytometry. Incontrast to 
Sh-SY5Y cells, no significant 
percentage (>5 %) of apoptotic 
cells were identified in NSC-34 
after treatment with SOD1G93a. 
NSC-34 cells were treated with 
10 µM thapsigargin (thaPS) 
for 4 h before harvesting as a 
positive control 
 
 
 
 
 
 
 
 
 
 
1 % protease inhibitor (Sigma), followed by incubation on 
ice for 10 min. the SDS soluble protein fraction was col- 
lected by centrifugation at 16 100 g for 10 min. For immu- 
noblotting, the cells were also treated with 0.125 % trypsin 
for 2 min at room temperature before lysis, to remove 
residual extracellular SOD1. 
 
Immunoblotting 
 
Protein samples (20 µg) electrophoresed through 10 % 
SDS–polyacrylamide gels or 10 % native PaGe (non- 
denaturing) gels and transferred to nitrocellulose mem- 
branes (Millipore). For the SDS-PaGe analysis of SOD1 
aggregates, the samples were prepared in sample loading 
buffer (0.042 M tris–hCl, 2 % SDS, 1 % glycine, 0.005 % 
bromophenol blue, 10 % glycerol, 100 mM iodoacetamide, 
4 % freshly added β mercaptoethanol). Membranes were 
blocked with 3 % (w/v) bovine serum albumin (BSa; 
Sigma), ph 8.0 for 1 h. the appropriate primary antibodies 
were prepared in 1 % (w/v) BSa solution as follows: SOD1 
(1:1000; Calbiochem), BiP (1:4000; Stressgen), Xbp1 
(1:400; SC), IRe1 (1:600; SC) and β actin as a loading con- 
trol (1:750; Sigma-aldrich). all antibodies were incubated 
with membranes for 1 h at room temperature (Rt). Blots 
were probed with hRP-conjugated donkey anti-sheep, goat 
anti-rabbit or goat anti-mouse antibodies at 1:2500 (Chemi- 
con) for 1 h at Rt and then developed using enhanced 
chemiluminescence (eCL) reagents (Roche). Quantifica- 
tion of band intensities was performed by densitometric 
analysis following subtraction of background using Image 
J (National Institutes of health, Bethesda, Ma, USa) and 
expressed relative to the corresponding signal for β-actin. 
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Blots were stripped using Reblot Plus solution (Chemicon) 
for 15 min, and then reprobed as above. 
VSVG transport assay 
Sh-SY5Y or NSC-34 cells were plated on 24-well plates 
with 13 mm coverslips. after 24 h in culture, cells were trans- 
fected with VSVG-ts045 tagged with fluorescent mCherry 
(a kind gift from Dr. Jennifer Lippincott-Schwartz and Dr. 
George Patterson) and another 24 h later cells were treated 
with extracellular SOD1 protein [35]. Following treatment 
for 24 h, cells were incubated at 40 °C for 24 h to accu- 
mulate VSVG-ts045 in the eR. Cycloheximide (20 µg/mL) 
was then added, and cells were shifted to 32 °C for 60 min 
or immediately fixed at 0 min. at each time interval, cells 
were washed with ice-cold PBS and fixed with 4 % PFa. 
the  eR  and  Golgi  compartments  were  immunostained 
with rabbit polyclonal anti-Calnexin antibody (abcam) and 
mouse monoclonal anti-GM130 antibody (BD transduc- 
tion Laboratories™) as described above. In each experiment 
20 cells were scored, and all experiments were performed 
in triplicate. Image analysis was performed using Image J 
using the JaCoP plugin to threshold and collect the Man- 
der’s coefficient [36] between the mCherry and far-red 
channels. 
 
annexin V binding assay to detect apoptotic cell death 
 
Sh-SY5Y  cells cultured in six-well plates were treated 
with extracellular SOD1 protein as above. the cells were 
harvested after 72 h treatment by adding trypsin for 1 min 
at  room  temperature.  the  cells  were  then  collected  in 
PBS, centrifuged at 1200 rpm for 5 min, and resuspended 
in 200 µl of annexin V binding buffer (10 mM hePeS, 
140 mM NaCl, 2.5 mM CaCl2, ph 7.4). the cell suspen- 
sion was treated with 3 µl of annexin V dye (Invitrogen) 
at room temperature for 15 min in the dark. annexin  V 
binding buffer (100 µl) was then added to the cell suspen- 
sion, counter-stained with 5 µg/mL of propidium iodide 
(PI, Sigma) and analyzed by BD FaCS Canto II flow 
cytometer. 
 
Statistical analyses 
 
Data are presented as mean ± standard error of the mean 
(SeM) from at least three independent experiments and 
were analyzed by one-way aNOVa  followed by tukey’s 
post hoc test using Prism 5.0 GraphPad Software. a value 
of P < 0.05 was considered significant. 
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